APA (7th ed.) Citation

Agrawal, D., Cisarova, K., Vosberg, S., Allmendinger, F., Munkhbaatar, E., Dandachi, N., . . . Jost, P. J. (2026). Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression. Science Advances, 12(4), 1. https://doi.org/10.1126/sciadv.adz9227

Chicago Style (17th ed.) Citation

Agrawal, Deepti, et al. "Aberrant Methylation Limits Antitumoral Inflammation in Lung Adenocarcinoma by Restricting RIPK3 Expression." Science Advances 12, no. 4 (2026): 1. https://doi.org/10.1126/sciadv.adz9227.

MLA (9th ed.) Citation

Agrawal, Deepti, et al. "Aberrant Methylation Limits Antitumoral Inflammation in Lung Adenocarcinoma by Restricting RIPK3 Expression." Science Advances, vol. 12, no. 4, 2026, p. 1, https://doi.org/10.1126/sciadv.adz9227.